Local
Lame, suffocated and dead: The drug supersizing America’s cattle
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: Wausau Pilot and Review

By Juan Vassallo, Investigate Midwest This series is supported by a grant from the Fund for Investigative Journalism. This story may not be republished by other news outlets until Nov. 10, 2026. In 2018, the U.S. Food and Drug Administration reviewed a first-of-its-kind cattle drug. Elanco Animal Health was seeking approval for Experior, a drug that contains an active ingredient from a controversial class of growth-promoting pharmaceuticals. These drugs can make farm animals gain more weight from the same amount of feed. Some are banned or restricted in more than 160 countries, largely over human safety concerns. But the Indiana-based pharmaceutical company did not seek Experior’s approval as a growth-promoting drug. Instead, it submitted Experior as a novel solution to an environmental problem. Most cattle raised for beef in the U.S. spend their final months in feedlots, where manure and urine release harmful gases, including ammonia.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Wausau Pilot and Review



